Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors-Reference-Cited by-同舟云学术

Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors

Published:2019-12 Issue: Volume:30 Page:x27-x42
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Brandão M.^ORCID,Caparica R.^ORCID,Eiger D.^ORCID,de Azambuja E.^ORCID

Funder

European Society for Medical Oncology

ESMO

Medical Research Fellowship at Institut Jules Bordet

Novartis

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/30/Supplement_10/x27/31574988/mdz280.pdf

Reference71 articles.

1. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer;Baselga;N Engl J Med,2012

2. Targeting the PI3K pathway in cancer: are we making headway?;Janku;Nat Rev Clin Oncol,2018

3. PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system;Beaver;Clin Cancer Res,2013

4. Predictive biomarkers of sensitivity to the phosphatidylinositol 3′ kinase inhibitor GDC-0941 in breast cancer preclinical models;O’Brien;Clin Cancer Res,2010

5. Phase II randomized preoperative window-of-opportunity study of the PI3K inhibitor pictilisib plus anastrozole compared with anastrozole alone in patients with estrogen receptor-positive breast cancer;Schmid;J Clin Oncol,2016

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and prospects of persistent luminescent materials in public health applications;Chemical Engineering Journal;2024-05

2. Hydroxychloroquine interaction with phosphoinositide 3-kinase modulates prostate cancer growth in bone microenvironment: In vitro and molecular dynamics based approach;International Journal of Biological Macromolecules;2024-05

3. Somatic Mutations in Latin American Breast Cancer Patients: A Systematic Review and Meta-Analysis;Diagnostics;2024-01-29

4. Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway;Journal of Translational Medicine;2024-01-03

5. Importance of Biomarker Conversions as “Road Signs” to Manage Women with Metastatic Breast Cancer: How To Use Them for Personalized Care of These Patients?;The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach;2023-12-18